T-cadinol and calamenene induce dendritic cells from human monocytes and drive Th1 polarization

European Journal of Pharmacology

Volumn 537, Issue 1-3, 2006, Pages 190-199

  Takei, Masao ^a   Umeyama, Akemi ^b   Arihara, Shigenobu ^b  

^a Research Center Borstel   (Germany)

^b TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

Cholera toxin; Dendritic cell; Sesquiterpene; Th1 response; Th2 response

Indexed keywords

B7 ANTIGEN; CALAMENENE; CALCIUM ION; CD83 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CHOLERA TOXIN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; NIFEDIPINE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 4; SESQUITERPENE DERIVATIVE; T CADINOL; T6 ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CANCER IMMUNOTHERAPY; CELL ASSAY; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; EXAMINATION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE REACTION; MONOCYTE; NORMAL HUMAN; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; PROTEIN INDUCTION; QUANTITATIVE ANALYSIS; STANDARD; T LYMPHOCYTE ACTIVATION; TH1 CELL;

ANTIGENS, SURFACE; CALCIUM; CELL DIFFERENTIATION; CELL MOVEMENT; CRYPTOMERIA; CYTOKINES; DENDRITIC CELLS; ENDOCYTOSIS; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-4; LYMPHOCYTE CULTURE TEST, MIXED; MONOCYTES; RECEPTORS, CHEMOKINE; RNA, MESSENGER; TERPENES; TH1 CELLS;

EID: 33646161474     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.02.047     Document Type: Article

References (43)

1. Arihara S., Umeyama A., Bando S., Imoto S., Ono M., Tani M., and Yoshikawa K. A new abietane and two dimeric abietane diterpens from the Black Heartwood of Cryptomeria japonica. Chem. Pharm. Bull. 52 (2004) 354-358
2. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 106 (1998) 245-252
3. Brightbill H., Libratry D.H., Krutzik S.R., Yang R.B., Belisel J.B., et al. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptor. Science 285 (1999) 732-738
4. Brossart P., Zobywalski A., and Grunebac F. Tumor necrosis factor A and CD 40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells. Cancer Res. 60 (2000) 4485-4492
5. Brunda M.J., Luistro L., Warrier R.R., Wright R.B., Hubbard B.R., Murphy M., Wolf S.F., and Gately M.K. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med. 78 (1993) 1223-1226
6. Cella M., Scheidegger D., Palmer-Lehmann K., Lane P., Lanzavecchia A., and Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184 (1996) 747-752
7. Cella M., Salio M., Sakakibara Y., Langen H., Julkunen I., and Lanzavecchia A. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189 (1999) 821-829
8. Claeson P., Andersson R., and Samuelsson G. T-cadinol: a pharmacologically active constitute of scented myrrh: introductory pharmacological characterization and high field 1H- and 13C-NMR data. Plant. Med. 57 (1991) 352-356
9. Claeson P., Zygmunt P., and Hogstatt E.D. Calcium-antagonistic properties of the sesquiterpene T-cadinol: a comparison with nimodipine in the isolated rat aorta. Pharmacol. Toxicol. 69 (1991) 173-177
10. Delespesse G., Ohshima Y., Shu .U., Yang L.P., Demeure C., Wu Y., Byun D.G., and Sarfat M. Differentiation of naïve human CD4 T cells into Th2/Th1 effectors. Allergol. Int. 46 (1997) 63-72
11. Fong L., and Engelman E.G. Dendritic cells in cancer immunotherapy. Annu. Rev. Immunol. 18 (2000) 245-273
12. Forster R., Schubel A., and Breitfeld D. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99 (1999) 23-33
13. Gagliardi M.C., Sallusto F., Marinaro M., Langenkamp A., Lanzavecchia A., and De Magistris M.T. Cholera toxin induces maturation of human dendritic cells and licenses them for Th2 priming. Eur. J. Pharmacol. 30 (2000) 2394-2403
14. Grage-Griebenow E., Lorenzen D., Fetting R., Flad H.D., and Ernst M. Phenotypical and functional characterisation of FCγ receptor 1 (CD64)-negative Mo, a minor human mo subpopulation with high accessory and antiviral activity. Eur. J. Immunol. 23 (1993) 3126-3131
15. Gurney A.M., Nerbonne J.M., and Lester H.A. Photoinduced removal of nifedipine reveals mechanisms of calcium antagonist action on single heart cells. J. Gen. Physiol. 86 (1985) 353-379
16. Hartmann G., Weiner G.J., and Krieg A.M. CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 9305-9310
17. Hsieh C.S., Macatonia S.E., Tripp C.S., Wolf S.F., O'garra A., and Murphy K.M. Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260 (1993) 547-549
18. Höuken U.E., Droese J., Jorgensen J., Breitfeld D., Zerwes H.-G., and Lipp M. The chemokines receptor CCR7 control lymphonode-dependent cytotoxic T cell priming in alloimmune responses. Eur. J. Immunol. 34 (2004) 461-470
19. Iezzi G., Scotet E., Scheidegger D., and Lanzavecchia A. The interplay between the duration of TCR and cytokine signaling determines T cell polarization. Eur. J. Immunol. 29 (1999) 4092-4101
20. Jonuleit H., Kuhn U., and Muller G. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 27 (1997) 3135-3142
21. Kato M., Neil T.K., Fearnley D.B., McLellan A.D., Vuckovic S., and Hart D.N.J. Expression of multilectin receptors and comparative FITC-dextran uptake by human dendritic cells. Int. Immunol. 12 (2000) 1511-1519
22. Kuchroo V.K., Dasa M.P., Brown J.A., Ranger A.M., Zamvil S.S., Sobel R.A., Weiner H.L., Nabavi N., and Glimcheri L.H. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 development pathways: application to autoimmune disease therapy. Cell 80 (1995) 707-713
23. Lanzavecchia A., and Sallustoa A.F. Regulation of T cell immunity by dendritic cells. Cell 106 (2001) 263-266
24. Lederer J.A., Perez V.L., Desroches L., Kim S.M., Abbas A., and Lichtman A.H. Cytokine transcriptional events during helper T cell subset differentiation. J. Exp. Med. 184 (1996) 397-406
25. Mellman I., and Steinman R.M. Dendritic cells: specialized and regulated antigen processing machines. Cell 106 (2001) 2555-2558
26. Nair S., McLaughlin C., Weizer A., Su Z., Boczkowski D., Dannull J., and Giloboa E. Injection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturation. J. Immunol. 171 (2003) 6275-6282
27. O'garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8 (2001) 275-278
28. O'garra A., and Murphy K. T-cell subsets in autoimmunity. Curr. Opin. 5 (1993) 880-886
29. Okamoto M., and Sato M. Toll-like receptor signaling in anti-cancer immunity. J. Med. Invest. 50 (2003) 9-24
30. Romagnani S. Lymphokine production by human T cells in disease state. Annu. Rev. Immunol. 12 (1994) 227-257
31. Salio M., Cerundolo V., and Lanzavecchia A. Dendritic cell maturation is induced by mycoplasma infection but not necrotic cells. Eur. J. Immunol. 30 (2000) 705-708
32. Steinman R.M., and Dhodapkar M. Active immunization against cancer with dendritic cells: the near future. Int. J. Cancer 95 (2001) 459-473
33. Takei M., Nakagawa H., and Endo K. Mast cell activation by pedicellarial toxin of sea urchin, Tosopneustes pileolus. FEBS Lett. 328 (1993) 59-62
34. Takei M., Tachikawa E., Hasegawa H., and Lee J.J. Dendritic cells maturation promoted by M1 and M4, end products of steroidal ginseng saponins metabolized in digestive tracts, drive a potent Th1 polarization. Biochem. Pharmacol. 68 (2004) 441-452
35. Tanaka H., Demeure C.E., Rubio M., Delespesse G., and Sarfati M. Human monocyte-derived dendritic cells induce naïve T cell differentiation into T helper cell type 2 (Th2) or TH1/Th2 effectors: role of stimulator/responder ratio. J. Exp. Med. 192 (2000) 405-411
36. Tao X., Grant C., Constant S., and Bottomly K. Induction of IL-4-producing CD4+ T cells by antigenic peptides altered for TCR binding. J. Immunol. 158 (1997) 4237-4244
37. Thulin M., and Claeson P. The botanical origin of scented myrrh (bissabol or habak hadi). Econ. Bot. 45 (1991) 487-494
38. Trinchieri G., and Scott P. The role of interleukin 12 in the immune response, disease and therapy. Immunol. Today 15 (1994) 460-463
39. Vieira P.L., de Jong D.C., Wierenga E.A., Kapsenberg M.L., and Kalinski P. Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J. Immunol. 164 (2000) 4507-4512
40. Whiteside T.L., and Odoux C. Dendritic cell biology and cancer therapy. Cancer Immunol. Immunother. 53 (2004) 240-248
41. Wilson A.D., Bailey M., Williams N.A., and Stokes C.R. The in vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant. Eur. J. Immunol. 21 (1991) 2333-2339
42. Xu-Amano J., Kiyono H., Jackson R.L., Staats H.F., Fujihashi K., Burrows P.D., Elson C.O., Pillai S., and McGhee J.R. Helper T cells subsets for immunoglobulin a responses; oral immunization with tetanus toxin and cholera toxin as adjuvant selectively induces Th2 cells in mucosa-associated tissues. J. Exp. Med. 178 (1993) 1309-1320
43. Zygmunt P.M., Larsson B., Sterner O., Vinge E., and Hogestatt E.D. Calcium antagonistic properties of the sesquiterpene T-cadinol and related substances: structure-activity studies. Pharmacol. Toxicol. 73 (1993) 3-9